137 related articles for article (PubMed ID: 17662189)
1. Vascular retention of Tc-99m pertechnetate and Tc-99m sestamibi, mimicking thyroid carcinoma metastases.
Tuncel M; Ozgen Kiratli P
Rev Esp Med Nucl; 2007; 26(4):226-9. PubMed ID: 17662189
[No Abstract] [Full Text] [Related]
2. Incidental finding of hiatal hernia on (99m)Tc-sestamibi whole-body scan in thyroid cancer evaluation.
Del Castillo-Matos R; Quirce R; Martínez-Rodríguez I; Medina-Quiroz P; Rubio-Vassallo A; Carril JM
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):163-4. PubMed ID: 22056002
[No Abstract] [Full Text] [Related]
3. Accumulation of technetium-99m pertechnetate in a patient with metastases of thyroid carcinoma.
Yamamoto Y; Nishiyama Y; Ono Y; Satoh K; Ohkawa M; Kawasaki Y; Tanabe M
Ann Nucl Med; 1999 Oct; 13(5):357-9. PubMed ID: 10582808
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-pertechnetate whole-body SPET/CT scan in thyroidectomized differentiated thyroid cancer patients is a useful imaging modality in detecting remnant thyroid tissue, nodal and distant metastases before
Lou K; Gu Y; Hu Y; Wang S; Shi H
Hell J Nucl Med; 2018; 21(2):121-124. PubMed ID: 30089313
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic capabilities of I-131, TI-201, and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy.
Fujie S; Okumura Y; Sato S; Akaki S; Katsui K; Himei K; Takemoto M; Kanazawa S
Acta Med Okayama; 2005 Jun; 59(3):99-107. PubMed ID: 16049563
[TBL] [Abstract][Full Text] [Related]
6. Cystic parathyroid adenoma: Primary hyperparathyroidism without
Oliver Guillén JR; de la Cueva Barrao L; Miguelena Bobadilla JM; Giménez Maurel T; Hernando Almudí E; Casamayor Franco MC
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):254-256. PubMed ID: 28392334
[TBL] [Abstract][Full Text] [Related]
7. Thymic uptake of iodine-131 in the anterior mediastinum.
Veronikis IE; Simkin P; Braverman LE
J Nucl Med; 1996 Jun; 37(6):991-2. PubMed ID: 8683329
[TBL] [Abstract][Full Text] [Related]
8. Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
Meller B; Sahlmann C; Horstmann O; Gerl J; Baehre M; Meller J
Nuklearmedizin; 2005; 44(3):N23-5. PubMed ID: 15997503
[No Abstract] [Full Text] [Related]
9. Preoperative scintigraphic visualization of an orbital metastasis before identification of carcinoma in a nonfunctioning thyroid nodule.
Boughattas S; Khochtali H; Arifa N; Degdegui M; Hassine H; Bakir A; Essabbah H
Clin Nucl Med; 2004 Apr; 29(4):249-50. PubMed ID: 15096972
[TBL] [Abstract][Full Text] [Related]
10. [Primary hyperparathyroidism in patients treated for non-medullary thyroid carcinoma].
Rubello D; Pagetta C; Pelizzo MR; Casara D
Minerva Endocrinol; 2001 Mar; 26(1):31-4. PubMed ID: 11323565
[TBL] [Abstract][Full Text] [Related]
11. Postsurgical thyroid remnant estimation by (⁹⁹m) Tc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.
Giovanella L; Suriano S; Ricci R; Ceriani L; Anton Verburg F
Head Neck; 2011 Apr; 33(4):552-6. PubMed ID: 20824809
[TBL] [Abstract][Full Text] [Related]
12. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
13. [High retention of (99m)Tc-MIBI in delayed phase as a pitfall in the combined parathyroid-thyroid scintigraphy].
Verdú J; Lizárraga C; Clavel J; Prata I; Calbo J; Pomares F
Rev Esp Med Nucl; 2010; 29(5):251-3. PubMed ID: 20381207
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland scintigraphy after radioiodine therapy.
Malpani BL; Samuel AM; Jaiswar RK
Nucl Med Commun; 1998 Feb; 19(2):183-4. PubMed ID: 9548203
[No Abstract] [Full Text] [Related]
15. Negative remnant
Lan W; Gege Z; Ningning L; Qiang W; Lin B; Qingjie M; Bin J
Ann Nucl Med; 2019 Feb; 33(2):112-118. PubMed ID: 30374858
[TBL] [Abstract][Full Text] [Related]
16. "Hot" carcinoma of the thyroid. Case reports and comments on the literature.
Lupi A; Orsolon P; Cerisara D; Deantoni Migliorati G; Vianello Dri A
Minerva Endocrinol; 2002 Mar; 27(1):53-7. PubMed ID: 11845114
[TBL] [Abstract][Full Text] [Related]
17. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
[TBL] [Abstract][Full Text] [Related]
18. Gamma probe-guided resection and scanning with TC-99m MIBI of a local recurrence of follicular thyroid carcinoma.
Boz A; Arici C; Güngör F; Yildiz A; Colak T; Karayalçin B
Clin Nucl Med; 2001 Oct; 26(10):820-2. PubMed ID: 11564916
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of extra-thyroid
Long B; Yao LF; Chen SC; Shui J; Ye XM; Yi HQ; Lou C
J Int Med Res; 2021 May; 49(5):3000605211012667. PubMed ID: 34024177
[TBL] [Abstract][Full Text] [Related]
20. Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma.
Almeida-Filho P; Ravizzini GC; Almeida C; Borges-Neto S
Clin Nucl Med; 2000 Jun; 25(6):443-6. PubMed ID: 10836693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
